keyword
https://read.qxmd.com/read/38553593/regulation-of-hippo-signaling-mediated-apoptosis-by-rauvolfia-tetraphylla-in-triple-negative-breast-cancer
#1
JOURNAL ARTICLE
B Balavaishnavi, M Kamaraj, T G Nithya, P Santhosh, S GokilaLakshmi, Mohammed Rafi Shaik
Rauvolfia tetraphylla is an essential medicinal plant that has been widely used in traditional medicine for various disease treatments. However, the tumor suppressor activity of R. tetraphylla and its phytocompounds were not explored against triple-negative breast cancer. The current research investigated the impact of R. tetraphylla methanolic extract (RTE) and its isolated compounds Ajmaline (RTC1) and Reserpine (RTC2) on triple-negative breast cancer cell line (MDA-MB-231) focusing on anti-proliferative effects...
March 29, 2024: Medical Oncology
https://read.qxmd.com/read/38477371/endocardial-repolarization-dispersion-in-brs-a-novel-automatic-algorithm-for-mapping-activation-recovery-interval
#2
JOURNAL ARTICLE
Sara Latrofa, Valentina Hartwig, Lorenzo Bachi, Pasquale Notarstefano, Silvia Garibaldi, Luca Panchetti, Martina Nesti, Paolo Seghetti, Umberto Startari, Gianluca Mirizzi, Maria Sole Morelli, Martina Modena, Andrea Mazzanti, Michele Emdin, Alberto Giannoni, Andrea Rossi
INTRODUCTION: Repolarization dispersion in the right ventricular outflow tract (RVOT) contributes to the type-1 electrocardiographic (ECG) phenotype of Brugada syndrome (BrS), while data on the significance and feasibility of mapping repolarization dispersion in BrS patients are scarce. Moreover, the role of endocardial repolarization dispersion in BrS is poorly investigated. We aimed to assess endocardial repolarization patterns through an automated calculation of activation recovery interval (ARI) estimated on unipolar electrograms (UEGs) in spontaneous type-1 BrS patients and controls; we also investigated the relation between ARI and right ventricle activation time (RVAT), and T-wave peak-to-end interval (Tpe) in BrS patients...
March 13, 2024: Journal of Cardiovascular Electrophysiology
https://read.qxmd.com/read/38333419/non-invasive-cardiac-activation-mapping-and-identification-of-severity-of-epicardial-substrate-in-brugada-syndrome-a-case-report
#3
Saverio Iacopino, Paolo Sorrenti, Giuseppe Campagna, Gennaro Fabiano, Emmanuel Fabiano, Jacopo Colella
INTRODUCTION: It has recently been shown that electrocardiographic imaging (ECGi) can be employed in individuals undergoing an ajmaline test who have Brugada Syndrome (BrS), to evaluate the extent of substrate-involved arrhythmia in the right ventricular overflow tract (RVOT). For the first time, we stratify the risk of sudden cardiac death (SCD) in BrS during ajmaline testing using the dST-Tiso interval (a robust predictor of the inducibility of ventricular arrhythmias (VAs) in the presence of drug-induced BrS type-1 pattern) in combination with ECGi technology...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38252933/high-risk-brugada-syndrome-factors-associated-with-arrhythmia-recurrence-and-benefits-of-epicardial-ablation-in-addition-to-icd-implantation
#4
JOURNAL ARTICLE
Vincenzo Santinelli, Giuseppe Ciconte, Francesco Manguso, Luigi Anastasia, Emanuele Micaglio, Zarko Calovic, Gabriele Vicedomini, Beniamino Mazza, Mattia Vecchi, Valerio Mecarocci, Emanuela T Locati, Antonio Boccellino, Gabriele Negro, Antonio Napolano, Luigi Giannelli, Carlo Pappone
AIMS: This study aims to evaluate the prognostic impact of the arrhythmogenic substrate size in symptomatic Brugada Syndrome (BrS) as well as to validate the long-term safety and effectiveness of epicardial radiofrequency ablation (RFA) compared to No-RFA group. METHODS AND RESULTS: In this prospective investigational long-term registry study, 257 selected symptomatic BrS patients with ICD implantation were included. Among them, 206 patients underwent radiofrequency epicardial ablation (RFA) and were monitored for over 5 years post-ablation (RFA group) while 51 patients received only ICD implantation declining RFA...
January 22, 2024: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://read.qxmd.com/read/38212296/de-novo-biosynthesis-of-antiarrhythmic-alkaloid-ajmaline
#5
JOURNAL ARTICLE
Jun Guo, Di Gao, Jiazhang Lian, Yang Qu
The antiarrhythmic drug ajmaline is a monoterpenoid indole alkaloid (MIA) isolated from the Ayurvedic plant Rauvolfia serpentina (Indian Snakeroot). Research into the biosynthesis of ajmaline and another renowned MIA chemotherapeutic drug vinblastine has yielded pivotal advancements in the fields of plant specialized metabolism and engineering over recent decades. While the majority of vinblastine biosynthesis has been recently elucidated, the quest for comprehending ajmaline biosynthesis remains incomplete, marked by the absence of two critical enzymes...
January 11, 2024: Nature Communications
https://read.qxmd.com/read/38155576/a-chromosome-scale-genome-assembly-of-rauvolfia-tetraphylla-facilitates-the-identification-of-the-complete-ajmaline-biosynthetic-pathway
#6
JOURNAL ARTICLE
Enzo Lezin, Inês Carqueijeiro, Clément Cuello, Mickael Durand, Hans J Jansen, Valentin Vergès, Caroline Birer Williams, Audrey Oudin, Thomas Duge De Bernonville, Julien Petrignet, Noémie Celton, Benoit St-Pierre, Nicolas Papon, Chao Sun, Ron P Dirks, Sarah Ellen O'Connor, Michael Krogh Jensen, Sébastien Besseau, Vincent Courdavault
No abstract text is available yet for this article.
December 27, 2023: Plant communications
https://read.qxmd.com/read/38045442/electrocardiographic-temporo-spatial-assessment-of-depolarization-and-repolarization-changes-after-epicardial-arrhythmogenic-substrate-ablation-in-brugada-syndrome
#7
JOURNAL ARTICLE
Emanuela T Locati, Peter M Van Dam, Giuseppe Ciconte, Francesca Heilbron, Machteld Boonstra, Gabriele Vicedomini, Emanuele Micaglio, Žarko Ćalović, Luigi Anastasia, Vincenzo Santinelli, Carlo Pappone
AIMS: In Brugada syndrome (BrS), with spontaneous or ajmaline-induced coved ST elevation, epicardial electro-anatomic potential duration maps (epi-PDMs) were detected on a right ventricle (RV) outflow tract (RVOT), an arrhythmogenic substrate area (AS area), abolished by epicardial-radiofrequency ablation (EPI-AS-RFA). Novel CineECG, projecting 12-lead electrocardiogram (ECG) waveforms on a 3D heart model, previously localized depolarization forces in RV/RVOT in BrS patients. We evaluate 12-lead ECG and CineECG depolarization/repolarization changes in spontaneous type-1 BrS patients before/after EPI-AS-RFA, compared with normal controls...
December 2023: European heart journal. Digital health
https://read.qxmd.com/read/38018776/discovery-of-unusual-ajmaline-macroline-type-bisindole-alkaloids-from-alstonia-macrophylla-by-building-blocks-based-molecular-networking
#8
JOURNAL ARTICLE
Zi-Wei Li, Chun-Lin Fan, Biao Sun, Lan Huang, Zi-Qi Wang, Xiao-Jun Huang, Shi-Qin Zhang, Wen-Cai Ye, Zhen-Long Wu, Xiao-Qi Zhang
Three unusual ajmaline-macroline type bisindole alkaloids, alsmaphylines A-C, together with their postulated biogenetic precursors, were isolated from the stem barks and leaves of Alstonia macrophylla via the building blocks-based molecular network (BBMN) strategy. Alsmaphyline A represents a rare ajmaline-macroline type bisindole alkaloid with an S-shape polycyclic ring system. Alsmaphylines B and C are two novel ajmaline-macroline type bisindole alkaloids with N-1-C-21' linkages, and the former possesses an unconventional stacked conformation due to the presence of intramolecular noncovalent interactions...
November 29, 2023: Chemistry: a European Journal
https://read.qxmd.com/read/37944131/identification-of-brugada-syndrome-based-on-p-wave-features-an-artificial-intelligence-based-approach
#9
JOURNAL ARTICLE
Beatrice Zanchi, Francesca Faraci, Ali Gharaviri, Marco Bergonti, Tomas Monga, Angelo Auricchio, Giulio Conte
BACKGROUND AND AIMS: Brugada syndrome (BrS) is an inherited disease associated with an increased risk of ventricular arrhythmias. Recent studies have reported the presence of an altered atrial phenotype characterized by abnormal P-wave parameters. The aim of this study was to identify BrS based exclusively on P waves features through an artificial intelligence (AI)-based model. METHODS: Continuous 5-minute 12-lead ECG recordings were obtained in sinus rhythm from a) patients with spontaneous or ajmaline-induced BrS and no history of AF and b) subjects with suspected BrS and negative ajmaline challenge...
November 7, 2023: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://read.qxmd.com/read/37772950/patient-reported-outcome-measures-on-mental-health-and-psychosocial-factors-in-patients-with-brugada-syndrome
#10
JOURNAL ARTICLE
Stefaan Six, Peter Theuns, Pieter Libin, Ann Nowé, Luigi Pannone, Bart Bogaerts, Simon Jaxy, Catharina Olsen, Gudrun Pappaert, Isel Grau, Juan Sieira, Sonia Van Dooren, Esther Scheirlynck, Julie Nekkebroeck, Marina Mallefroy, Carlo de Asmundis, Johan Bilsen
AIMS: Brugada syndrome (BrS) is a hereditary arrhythmic disease, associated with sudden cardiac death. To date, little is known about the psychosocial correlates and impacts associated with this disease. The aim of this study was to assess a set of patient-reported psychosocial outcomes, to better profile these patients, and to propose a tailored psychosocial care. METHODS AND RESULTS: Patients were recruited at the European reference Centre for BrS at Universitair Ziekenhuis Brussel, Belgium...
August 2, 2023: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://read.qxmd.com/read/37688842/can-specific-ecg-markers-identify-a-pharmacologically-induced-type-1-brugada-pattern-insights-from-a-large-single-center-cohort
#11
JOURNAL ARTICLE
Eraldo Occhetta, Federica De Vecchi, Lorella Barbonaglia, Chiara Devecchi, Mario Matta, Maurizio Malacrida, Giuseppe Patti, Francesco Rametta
BACKGROUND: In patients with a type 2 or 3 Brugada pattern, the pharmacological (IC drugs) induction of a type 1 pattern confirms the diagnosis of Brugada syndrome. OBJECTIVE: To evaluate the value of various ECG markers in predicting IC drug test results. METHODS: We retrospectively analysed 443 consecutive patients referred to our Center (from January 2010 to December 2019) to undergo Ajmaline/Flecainide testing; all had a type 2 or 3 Brugada pattern or were relatives with Brugada syndrome...
2023: Journal of Electrocardiology
https://read.qxmd.com/read/37565952/atrial-abnormalities-in-brugada%C3%A2-syndrome-evaluation-with-ecg-imaging
#12
JOURNAL ARTICLE
Antonio Bisignani, Luigi Pannone, Alvise Del Monte, Ivan Eltsov, Ida Anna Cappello, Juan Sieira, Cinzia Monaco, Gezim Bala, Sahar Mouram, Domenico Giovanni Della Rocca, Erwin Ströker, Ingrid Overeinder, Alexandre Almorad, Gudrun Pappaert, Anaïs Gauthey, Thomy de Ravel, Sonia Van Dooren, Antonio Sorgente, Mark La Meir, Andrea Sarkozy, Pedro Brugada, Gian-Battista Chierchia, Carlo de Asmundis
BACKGROUND: Patients with Brugada syndrome (BrS) have an increased risk of arrhythmias, including atrial tachyarrhythmias (ATas). OBJECTIVES: The purpose of this study was to assess underlying atrial cardiomyopathy in BrS and the effect of ajmaline (AJM) test on the atrium of BrS patients using electrocardiogram imaging (ECGI). METHODS: All consecutive patients diagnosed with BrS in a monocentric registry were screened and included if they met the following criteria: 1) BrS diagnosed following current recommendations; and 2) ECGI map performed before and after AJM with a standard protocol...
October 2023: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/37485210/unmasking-idiopathic-brugada-ecg-pattern-inducible-type-1-brugada-pattern-in-a-young-patient-and-clinical-implications
#13
Hajar El Ouartassi, Badre El Boussaadani, Raid Faraj, Ibtissam Fellat, Mohamed Cherti
Brugada syndrome is a rare inherited channelopathy associated with an increased risk of ventricular tachycardia and ventricular fibrillation, leading to syncope and sudden cardiac death. We present a case report of a young patient with an inducible type 1 Brugada pattern on an electrocardiogram (ECG), accompanied by a comprehensive literature review. The 19-year-old patient presented with dizziness and exhibited a type 2 Brugada pattern on admission ECG, which converted to a type 1 pattern following an Ajmaline test...
June 2023: Curēus
https://read.qxmd.com/read/37480873/left-ventricular-abnormal-substrate-in%C3%A2-brugada-syndrome
#14
JOURNAL ARTICLE
Ghassen Cheniti, Michel Haissaguerre, Christian Dina, Tsukasa Kamakura, Josselin Duchateau, Frederic Sacher, Hugo-Pierre Racine, Elodie Surget, Floriane Simonet, Jean-Baptiste Gourraud, Soumaya Sridi, Hubert Cochet, Clementine Andre, Benjamin Bouyer, Remi Chauvel, Romain Tixier, Nicolas Derval, Thomas Pambrun, Remi Dubois, Pierre Jais, Koonlawee Nademanee, Richard Redon, Jean-Jacques Schott, Vincent Probst, Meleze Hocini, Julien Barc, Olivier Bernus
BACKGROUND: Slow-conductive structural abnormalities located in the epicardium of the right ventricle (RV) underlie Brugada syndrome (BrS). The extent of such substrate in the left ventricle (LV) has not been investigated. OBJECTIVES: This study sought to characterize the extent of epicardial substrate abnormalities in BrS. METHODS: We evaluated 22 consecutive patients (mean age 46 ± 11 years, 21 male) referred for recurrent ventricular arrhythmias (mean 10 ± 13 episodes) in the setting of BrS...
June 28, 2023: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/37422009/phytochemistry-and-biological-activities-of-corynanthe-alkaloids
#15
REVIEW
Jun Li, Jia-Xing Li, Hua Jiang, Min Li, Lin Chen, Yue-Yue Wang, Lu Wang, Ning Zhang, He-Zhe Guo, Kai-Long Ma
Medicinal plants constitute a source for designing clinically useful drugs targeting diseases through various mechanisms. Plant secondary metabolites can be used as lead compounds of drugs. Corynanthe alkaloids are highly abundant natural bioactive substances of various core structures possessing important properties such as nerve excitation and antimalarial and analgesic effects. In this review, we summarize and review the state-of-the-art corynanthe-type alkaloid research focusing on phytochemistry, pharmacology, and structural chemistry...
July 6, 2023: Phytochemistry
https://read.qxmd.com/read/37159454/mechanisms-underlying-the-antiarrhythmic-effect-of-arumenamide-787-in-experimental-models-of-the-j-wave-syndromes-and-hypothermia
#16
JOURNAL ARTICLE
José M Di Diego, Hector Barajas-Martinez, Robert Cox, Victoria M Robinson, Joseph Jung, Mohamed Fouda, Mena Abdelsayed, Peter C Ruben, Charles Antzelevitch
BACKGROUND: Brugada (BrS) and early repolarization syndromes (ERS), the so-called J wave syndromes (JWS), are associated with life-threatening ventricular arrhythmias. Pharmacologic approaches to therapy are currently limited. In this study, we examine the effects of ARumenamide-787 (AR-787) to suppress the electrocardiographic and arrhythmic manifestations of JWS and hypothermia. METHODS: We studied the effects of AR-787 on INa and IKr in HEK-293 cells stably expressing the α- and β1-subunits of the cardiac (NaV1...
2023: PloS One
https://read.qxmd.com/read/37114354/simultaneous-presence-of-brugada-and-overgrowth-syndromes
#17
JOURNAL ARTICLE
Andrea Segreti, Francesco Piccirillo, Simone Pasquale Crispino, Francesca Cocchia, Arianna Martucciello, Vito Calabrese, Fiorella Gurrieri, Francesco Grigioni
In the present article, we describe the case of a 21-year-old male presenting to the Emergency Department following a syncopal episode. Physical examination revealed a distinctive facial appearance in the context of an overgrowth syndrome. Also, an ajmaline test was performed because of the evidence of an incomplete right bundle branch block with ST-T segment elevation in the right precordial derivations, revealing a type-1 Brugada electrocardiographic pattern. Considering the high cardiovascular risk phenotype, the patient underwent subcutaneous cardiac defibrillator implantation...
April 27, 2023: Monaldi Archives for Chest Disease
https://read.qxmd.com/read/37042261/ventricular-conduction-stability-noninvasively-identifies-an-arrhythmic-substrate-in-survivors-of-idiopathic-ventricular-fibrillation
#18
JOURNAL ARTICLE
Ji-Jian Chow, Kevin M W Leong, Matthew J Shun-Shin, Julian O M Ormerod, Michael Koa-Wing, David C Lefroy, Phang Boon Lim, Nicholas W F Linton, Fu Siong Ng, Norman A Qureshi, Zachary I Whinnett, Nicholas S Peters, Darrel P Francis, Amanda M Varnava, Prapa Kanagaratnam
Background Idiopathic ventricular fibrillation (VF) is a diagnosis of exclusion following normal cardiac investigations. We sought to determine if exercise-induced changes in electrical substrate could distinguish patient groups with various ventricular arrhythmic pathophysiological conditions and identify patients susceptible to VF. Methods and Results Computed tomography and exercise testing in patients wearing a 252-electrode vest were combined to determine ventricular conduction stability between rest and peak exercise, as previously described...
April 18, 2023: Journal of the American Heart Association
https://read.qxmd.com/read/36809945/review-on-pharmacognostic-phytochemical-and-pharmacological-characteristics-of-medicinal-plants-which-can-be-used-to-design-a-novel-ayurvedic-formulation-to-treat-hypertension-in-multidimensional-approaches
#19
JOURNAL ARTICLE
Rahul Maurya, Thirupataiah Boini, Lakshminarayana Misro, Thulasi R, Ravinder Singh
BACKGROUND: Hypertension is a cardiovascular disorder that is an incurable clinical condition. It requires lifelong therapy for its management along with long terms application of synthetic drugs associated with severe toxicity in multiple organs. However, the therapeutic application of herbal medicines to treat hypertension has gained considerable attention. The limitations and hurdles associated with conventional plant extract medications are their safety, efficacy, dose, and unknown biological activity...
February 21, 2023: Current Hypertension Reviews
https://read.qxmd.com/read/36724992/brugada-syndrome-and-job-fitness-report-of-three-cases
#20
JOURNAL ARTICLE
Stefano M Candura, Daniela Vanoli, Andrea Mazzanti, Luca D'Amato, Silvia G Priori, Fabrizio Scafa
Brugada syndrome (BrS) is an inherited arrhythmogenic disorder predisposing patients to a high risk of sudden cardiac death. Specific guidelines on the health surveillance of BrS workers are lacking. We report here three cases requiring assessment of specific job capacity, investigated with an interdisciplinary protocol including 24-hour Holter electrocardiography with modified precordial leads, pharmacological test with ajmaline, molecular genetic analysis, electrophysiological study with ventricular stimulation, risk stratification, and occupational medicine evaluation: (1) a female 42 yr-old company manager with positive ajmaline test and CACNA1C gene mutation (judged fit for the job with limitations regarding work-related stress); (2) a male 44 yr-old welder with positive ajmaline test, SCN5A gene mutation, and associated OSAS (obstructive sleep apnea syndrome), who was advised to refrain from night shifts and driving company vehicles; (3) a male 45 yr-old electrical technician with inducible ventricular tachyarrhythmia, who was implanted with a biventricular cardioverter defibrillator, and therefore recommended to avoid exposure to electromagnetic fields and working at heights...
February 2, 2023: Industrial Health
keyword
keyword
102261
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.